SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-22
👔
Werewolf Therapeutics, Inc.
@HOWL_InsiderForm 4 Filing: RA CAPITAL MANAGEMENT, L.P. Sells $145,918.85 of $HOWL
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Werewolf Therapeutics, Inc.
Ticker: $HOWL
Transaction Value
$145,918.85
Price/Share: $0.35
transaction date
2026-06-17
Shares: 416,911
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, RA CAPITAL MANAGEMENT, L.P., holds the title of 10% Owner at Werewolf Therapeutics, Inc..
On 2026-06-17, the insider transacted 416,911 shares.The shares were transacted at a weighted average price of $0.35 per share, resulting in a total market-relevant value of $145,918.85.
Executive Summary Summary
RA CAPITAL MANAGEMENT, L.P. (10% Owner) sold $146K of $HOWL
Post-Transaction Position: 4,268,448 shares
SEC Accession No: 0001231919-26-000688 (CIK: 1346824)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.